203 related articles for article (PubMed ID: 1384536)
1. The complement system in human reproduction.
Vanderpuye OA; Labarrere CA; McIntyre JA
Am J Reprod Immunol; 1992; 27(3-4):145-55. PubMed ID: 1384536
[TBL] [Abstract][Full Text] [Related]
2. Several vascular complement inhibitors are present on human sperm.
Bozas SE; Kirszbaum L; Sparrow RL; Walker ID
Biol Reprod; 1993 Mar; 48(3):503-11. PubMed ID: 7680906
[TBL] [Abstract][Full Text] [Related]
3. Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55).
Holmes CH; Simpson KL; Okada H; Okada N; Wainwright SD; Purcell DF; Houlihan JM
Eur J Immunol; 1992 Jun; 22(6):1579-85. PubMed ID: 1376264
[TBL] [Abstract][Full Text] [Related]
4. Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage.
Lublin DM; Coyne KE
J Exp Med; 1991 Jul; 174(1):35-44. PubMed ID: 1711565
[TBL] [Abstract][Full Text] [Related]
5. Induction of decay-accelerating factor by cytokines or the membrane-attack complex protects vascular endothelial cells against complement deposition.
Mason JC; Yarwood H; Sugars K; Morgan BP; Davies KA; Haskard DO
Blood; 1999 Sep; 94(5):1673-82. PubMed ID: 10477692
[TBL] [Abstract][Full Text] [Related]
6. Cooperation between decay-accelerating factor and membrane cofactor protein in protecting cells from autologous complement attack.
Brodbeck WG; Mold C; Atkinson JP; Medof ME
J Immunol; 2000 Oct; 165(7):3999-4006. PubMed ID: 11034410
[TBL] [Abstract][Full Text] [Related]
7. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein.
Kim YU; Kinoshita T; Molina H; Hourcade D; Seya T; Wagner LM; Holers VM
J Exp Med; 1995 Jan; 181(1):151-9. PubMed ID: 7528766
[TBL] [Abstract][Full Text] [Related]
8. Human lung cancer cell lines express cell membrane complement inhibitory proteins and are extremely resistant to complement-mediated lysis; a comparison with normal human respiratory epithelium in vitro, and an insight into mechanism(s) of resistance.
Varsano S; Rashkovsky L; Shapiro H; Ophir D; Mark-Bentankur T
Clin Exp Immunol; 1998 Aug; 113(2):173-82. PubMed ID: 9717965
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of complement regulatory proteins decay-accelerating factor (CD55), membrane cofactor protein (CD46) and CD59 during human spermatogenesis.
Simpson KL; Holmes CH
Immunology; 1994 Mar; 81(3):452-61. PubMed ID: 7515850
[TBL] [Abstract][Full Text] [Related]
10. Protection of human nasal respiratory epithelium from complement-mediated lysis by cell-membrane regulators of complement activation.
Varsano S; Frolkis I; Rashkovsky L; Ophir D; Fishelson Z
Am J Respir Cell Mol Biol; 1996 Dec; 15(6):731-7. PubMed ID: 8969267
[TBL] [Abstract][Full Text] [Related]
11. Complement regulatory activity of normal human intraocular fluid is mediated by MCP, DAF, and CD59.
Sohn JH; Kaplan HJ; Suk HJ; Bora PS; Bora NS
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4195-202. PubMed ID: 11095615
[TBL] [Abstract][Full Text] [Related]
12. Complement regulatory proteins in early human fetal life: CD59, membrane co-factor protein (MCP) and decay-accelerating factor (DAF) are differentially expressed in the developing liver.
Simpson KL; Houlihan JM; Holmes CH
Immunology; 1993 Oct; 80(2):183-90. PubMed ID: 7505254
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of complement regulators MCP (CD46), DAF (CD55) and protectin (CD59) in arthritic joint disease.
Davies ME; Horner A; Loveland BE; McKenzie IF
Scand J Rheumatol; 1994; 23(6):316-21. PubMed ID: 7528443
[TBL] [Abstract][Full Text] [Related]
14. Human nasal epithelium adsorbs complement C3-related fragments and expresses cell membrane complement regulatory proteins.
Varsano S; Frolkis I; Shapiro H; Ophir D
Laryngoscope; 1996 May; 106(5 Pt 1):599-604. PubMed ID: 8628088
[TBL] [Abstract][Full Text] [Related]
15. Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors.
Fishelson Z; Donin N; Zell S; Schultz S; Kirschfink M
Mol Immunol; 2003 Sep; 40(2-4):109-23. PubMed ID: 12914817
[TBL] [Abstract][Full Text] [Related]
16. Relative roles of decay-accelerating factor, membrane cofactor protein, and CD59 in the protection of human endothelial cells against complement-mediated lysis.
Brooimans RA; van Wieringen PA; van Es LA; Daha MR
Eur J Immunol; 1992 Dec; 22(12):3135-40. PubMed ID: 1280224
[TBL] [Abstract][Full Text] [Related]
17. Alternative complement pathway-mediated myeloid cell cytotoxicity: repertoire of membrane factors participating in regulation of C3 deposition and cytolysis.
Matsumoto M; Sugita Y; Seya T
Eur J Immunol; 1991 Aug; 21(8):1787-92. PubMed ID: 1714391
[TBL] [Abstract][Full Text] [Related]
18. Identification of the complement regulatory proteins CD46, CD55, and CD59 in human fallopian tube, endometrium, and cervical mucosa and secretion.
Jensen TS; Bjørge L; Wollen AL; Ulstein M
Am J Reprod Immunol; 1995 Jul; 34(1):1-9. PubMed ID: 7576125
[TBL] [Abstract][Full Text] [Related]
19. Protection of xenogeneic cells from human complement-mediated lysis by the expression of human DAF, CD59 and MCP.
Huang J; Gou D; Zhen C; Jiang D; Mao X; Li W; Chen S; Cai C
FEMS Immunol Med Microbiol; 2001 Oct; 31(3):203-9. PubMed ID: 11720816
[TBL] [Abstract][Full Text] [Related]
20. The change of membrane complement regulatory protein in chorion of early pregnancy.
Nishikori K; Noma J; Hirakawa S; Amano T; Kudo T
Clin Immunol Immunopathol; 1993 Nov; 69(2):167-74. PubMed ID: 7691457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
